Abstract
X-ray-induced afterglow and radiodynamic therapy tackle the tissue penetration issue of optical imaging and phototherapy. However, inorganic nanophosphors used in this therapy have their radio afterglow dynamic function as always on, limiting the detection specificity and treatment efficacy. Here we report organic luminophores (IDPAs) with near-infrared afterglow and 1O2 production after X-ray irradiation for cancer theranostics. The in vivo radio afterglow of IDPAs is >25.0 times brighter than reported inorganic nanophosphors, whereas the radiodynamic production of 1O2 is >5.7 times higher than commercially available radio sensitizers. The modular structure of IDPAs permits the development of a smart molecular probe that only triggers its radio afterglow dynamic function in the presence of a cancer biomarker. Thus, the probe enables the ultrasensitive detection of a diminutive tumour (0.64 mm) with superb contrast (tumour-to-background ratio of 234) and tumour-specific radiotherapy for brain tumour with molecular precision at low dosage. Our work reveals the molecular guidelines towards organic radio afterglow agents and highlights new opportunities for cancer radio theranostics.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All relevant data supporting the findings of this study are available within the Article and its Supplementary Information, or from the corresponding authors on reasonable request. Source data are provided with this paper.
References
Waterhouse, D. J., Fitzpatrick, C. R. M., Pogue, B. W., O’Connor, J. P. B. & Bohndiek, S. E. A roadmap for the clinical implementation of optical-imaging biomarkers. Nat. Biomed. Eng. 3, 339–353 (2019).
Lovell, J. F. et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 10, 324–332 (2011).
Lovell, J. F., Liu, T. W. B., Chen, J. & Zheng, G. Activatable photosensitizers for imaging and therapy. Chem. Rev. 110, 2839–2857 (2010).
Jiang, Y. & Pu, K. Molecular probes for autofluorescence-free optical imaging. Chem. Rev. 121, 13086–13131 (2021).
So, M. K., Xu, C., Loening, A. M., Gambhir, S. S. & Rao, J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat. Biotechnol. 24, 339–343 (2006).
Felsher, D. W. Cancer revoked: oncogenes as therapeutic targets. Nat. Rev. Cancer 3, 375–380 (2003).
Maldiney, T. et al. The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells. Nat. Mater. 13, 418–426 (2014).
le Masne de Chermont, Q. et al. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc. Natl Acad. Sci. USA 104, 9266–9271 (2007).
Miao, Q. et al. Molecular afterglow imaging with bright, biodegradable polymer nanoparticles. Nat. Biotechnol. 35, 1102–1110 (2017).
Wu, L. et al. H2S-activatable near-infrared afterglow luminescent probes for sensitive molecular imaging in vivo. Nat. Commun. 11, 446 (2020).
Jiang, Y. et al. A generic approach towards afterglow luminescent nanoparticles for ultrasensitive in vivo imaging. Nat. Commun. 10, 2064 (2019).
Chen, C. et al. Amplification of activated near-infrared afterglow luminescence by introducing twisted molecular geometry for understanding neutrophil-involved diseases. J. Am. Chem. Soc. 144, 3429–3441 (2022).
Withers, P. J. et al. X-ray computed tomography. Nat. Rev. Methods Primers 1, 18 (2021).
Pei, P. et al. X-ray-activated persistent luminescence nanomaterials for NIR-II imaging. Nat. Nanotechnol. 16, 1011–1018 (2021).
Chen, Z. Z. et al. Low dose of X-ray-excited long-lasting luminescent concave nanocubes in highly passive targeting deep-seated hepatic tumors. Adv. Mater. 31, 1905087 (2019).
Yi, Z., Luo, Z., Qin, X., Chen, Q. & Liu, X. Lanthanide-activated nanoparticles: a toolbox for bioimaging, therapeutics, and neuromodulation. Acc. Chem. Res. 53, 2692–2704 (2020).
Shi, T. et al. X-ray-induced persistent luminescence promotes ultrasensitive imaging and effective inhibition of orthotopic hepatic tumors. Adv. Funct. Mater. 30, 2001166 (2020).
Chen, H. et al. LiGa5O8:Cr-based theranostic nanoparticles for imaging-guided X-ray induced photodynamic therapy of deep-seated tumors. Mater. Horiz. 4, 1092–1101 (2017).
Huang, K. et al. Designing next generation of persistent luminescence: recent advances in uniform persistent luminescence nanoparticles. Adv. Mater. 34, 2107962 (2022).
Liu, J. et al. Imaging and therapeutic applications of persistent luminescence nanomaterials. Adv. Drug Deliv. Rev. 138, 193–210 (2019).
Ji, C., Tan, J. & Yuan, Q. Defect luminescence based persistent phosphors—from controlled synthesis to bioapplications. Chin. J. Chem. 39, 3188–3198 (2021).
Chen, W. & Zhang, J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol. 6, 1159–1166 (2006).
Chong, L. M., Tng, D. J. H., Tan, L. L. Y., Chua, M. L. K. & Zhang, Y. Recent advances in radiation therapy and photodynamic therapy. Appl. Phys. Rev. 8, 041322 (2021).
Wang, X. et al. Organic phosphorescent nanoscintillator for low-dose X-ray-induced photodynamic therapy. Nat. Commun. 13, 5091 (2022).
Overchuk, M., Cheng, M. H. Y. & Zheng, G. X-ray-activatable photodynamic nanoconstructs. ACS Cent. Sci. 6, 613–615 (2020).
Zhang, C. et al. Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence. Angew. Chem. Int. Ed. 54, 1770–1774 (2015).
Sun, W. et al. Aggregation-induced emission gold clustoluminogens for enhanced low dose X-ray-induced photodynamic therapy. Angew. Chem. Int. Ed. 59, 9914–9921 (2020).
Sun, W. et al. Monodisperse and uniform mesoporous silicate nanosensitizers achieve low-dose X-ray-induced deep-penetrating photodynamic therapy. Adv. Mater. 31, 1808024 (2019).
Deng, W. et al. Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Cent. Sci. 6, 715–726 (2020).
Hajagos, T. J., Liu, C., Cherepy, N. J. & Pei, Q. High-Z sensitized plastic scintillators: a review. Adv. Mater. 30, 1706956 (2018).
Wang, X. et al. Organic phosphors with bright triplet excitons for efficient X-ray-excited luminescence. Nat. Photon. 15, 187–192 (2021).
Rempel, S. A. et al. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54, 6027–6031 (1994).
Richard, C. & Viana, B. Persistent X-ray-activated phosphors: mechanisms and applications. Light.: Sci. Appl. 11, 123 (2022).
Pashayan, N. & Pharoah, P. D. P. The challenge of early detection in cancer. Science 368, 589–590 (2020).
Acknowledgements
K.P. thanks Singapore National Research Foundation (NRF) (NRF-NRFI07-2021-0005) and the Singapore Ministry of Education, Academic Research Fund Tier 1 (2019-T1-002-045, RG125/19, RT05/20) and Academic Research Fund Tier 2 (MOE-T2EP30220-0010, MOE-T2EP30221-0004) for financial support. R.Z. thanks the National Natural Science Foundation of China (nos. 82120108016 and 82071987) for financial support. J.S. thanks the National Natural Science Foundation of China (No. U22A20348, U21A20377) and the Natural Science Foundation of Fujian Province (No. 2020J02012).
Author information
Authors and Affiliations
Contributions
J.H., L.S. and C.X. contributed equally to this paper. K.P. conceived and designed the study. J.H. synthesized and characterized the molecules. L.S. performed the cell and animal studies. J.H., L.S., C.X., R.Z., J.S. and K.P. analysed the data and drew the figures. X.G. helped in the experiments. J.H., C.X. and K.P. drafted the manuscript. R.Z., J.S. and K.P. revised the manuscript. All authors contributed to the writing of this paper.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Materials thanks Cyrille Richard and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Radioafterglow mechanism and photophysical property study.
(a) Proposed radioafterglow mechanism of IDPASu and HRMS analysis of the new peaks at 6.0 (b) and 14.8 min (c) in Fig. 1g, confirming the generation of dioxetane intermediate and activated IDPASu. (d) Radioafterglow intensity of IDPASu as a function of its concentration in PBS (0.01 M, pH 7.4, 50% DMSO) after X-ray irradiation at 250 μGy•s−1 for 20 s. Data were presented as mean ± s.d (n = 3 independent experiments). (e) Temperature of PBS and IDPASu (100 mM) in PBS (0.01 M, pH 7.4, 50% DMSO) before and after X-ray irradiation at 250 μGy•s−1 for 20 s at room temperature. Data were presented as mean ± s.d (n = 3 independent experiments).
Supplementary information
Supplementary Information
Supplementary Figs. 1–19, Tables 1 and 2, methods and references.
Source data
Source Data Fig. 1
Statistical source data.
Source Data Fig. 2
Statistical source data.
Source Data Fig. 3
Statistical source data.
Source Data Fig. 4
Statistical source data.
Source Data Fig. 5
Statistical source data.
Source Data Extended Data Fig. 1
Statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, J., Su, L., Xu, C. et al. Molecular radio afterglow probes for cancer radiodynamic theranostics. Nat. Mater. 22, 1421–1429 (2023). https://doi.org/10.1038/s41563-023-01659-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-023-01659-1
This article is cited by
-
Illuminating cancer with sonoafterglow
Nature Photonics (2024)
-
Breaking the boundaries of biological penetration depth: X-ray luminescence in light theranostics
Science China Chemistry (2024)